Global Anti-Bumping Granules
Global Anti-Bumping Granules

Anti-Bumping Granules Comprehensive Study by Application (Laboratory chemicals, Manufacture of substances,, Scientific R&D), Type (Solid, White), Sale channel (Online, Offline, Retailer, Distributor, Hypermarket/supermarket, Others) Players and Region - Global Market Outlook to 2026

Anti-Bumping Granules Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Nov 2021 Edition 232 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Anti-Bumping Granules Market Scope
An Anti-bumping granule is a tiny, unevenly shaped piece of substance or component which is added to liquids in order to make them boil more calmly and effectively. Anti-bumping granules are mostly used for the distillation and heating process. Anti-bumping granule is made from aluminum oxide, AI203. Geographically, the north leading region in the consumption and adoption of anti-bumping granules due to huge application in the manufacturing industry. Hence this is a factor that is triggering the market growth over the forecast period

The Anti-Bumping Granules market study is segmented, by Application (Laboratory chemicals, Manufacture of substances, and Scientific R&D) and major geographies with country level break-up.

The market is expected to grow market in Manufacturing. It has been widely applied in well-sealing operations and is able to reduce pump pressure flow rate is driving the demand for the market. Several companies are operating in the market to provide customers with better offers with various features & unique offerings. The market is a highly consolidated market with the presence of several market players and local players. Which is triggering the market growth over the forecast period

Troemner LLC (United States), Merck (United States), Breckland Scientific (United Kingdom), VWR International, LLC (United Kingdom), BASF (Germany), Arkema (France), Nippon Shokubai (Japan), Mitsubishi Chemical (Japan), LG Chemical (South Korea), Evonik Industries (Germany), Dow Chemical Company (United States), Hexion(United States), OJSC Sibur (Moscow), Sasol (South Africa), Momentive Specialty Chemicals (United States) and Thomas Scientific (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Anti-Bumping Granules market by Type, Application and Region.

On the basis of geography, the market of Anti-Bumping Granules has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 21 January 2021, Thomas Scientific Accelerates Investments in Molecular Diagnostics Capabilities
On 19 August 2021, Thomas Scientific Launches Vendor Managed Inventory Solution


Market Drivers
  • Anti-bumping granule will prevent superheating of the liquid which being distilled
  • Anti-bumping granule will cause a more controlled boiler

Opportunities
  • It helps to cold the liquid
  • Anti-bumping granule mostly used for reflux procedure

Restraints
  • During refluxing process is bumping (superheating) a large amount of stringing process is required

Challenges
  • Overheating may damage the quality of the product


Key Target Audience
Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Anti-Bumping Granules Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Application
  • Laboratory chemicals
  • Manufacture of substances,
  • Scientific R&D
By Type
  • Solid
  • White

By Sale channel
  • Online
  • Offline
  • Retailer
  • Distributor
  • Hypermarket/supermarket
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Anti-bumping granule will prevent superheating of the liquid which being distilled
      • 3.2.2. Anti-bumping granule will cause a more controlled boiler
    • 3.3. Market Challenges
      • 3.3.1. Overheating may damage the quality of the product
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Anti-Bumping Granules, by Application, Type, Sale channel and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Anti-Bumping Granules (Value)
      • 5.2.1. Global Anti-Bumping Granules by: Type (Value)
        • 5.2.1.1. Solid
        • 5.2.1.2. White
      • 5.2.2. Global Anti-Bumping Granules by: Application (Value)
        • 5.2.2.1. Laboratory chemicals
        • 5.2.2.2. Manufacture of substances,
        • 5.2.2.3. Scientific R&D
      • 5.2.3. Global Anti-Bumping Granules by: Type (Value)
        • 5.2.3.1. Solid
        • 5.2.3.2. White
      • 5.2.4. Global Anti-Bumping Granules by: Sale channel (Value)
        • 5.2.4.1. Online
        • 5.2.4.2. Offline
        • 5.2.4.3. Retailer
        • 5.2.4.4. Distributor
        • 5.2.4.5. Hypermarket/supermarket
        • 5.2.4.6. Others
      • 5.2.5. Global Anti-Bumping Granules Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Anti-Bumping Granules (Price)
  • 6. Anti-Bumping Granules: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Troemner LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Breckland Scientific (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. VWR International, LLC (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BASF (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Arkema (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nippon Shokubai (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mitsubishi Chemical (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LG Chemical (South Korea)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Evonik Industries (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Dow Chemical Company (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Hexion(United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. OJSC Sibur (Moscow)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Sasol (South Africa)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Momentive Specialty Chemicals (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Thomas Scientific (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Anti-Bumping Granules Sale, by Application, Type, Sale channel and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Anti-Bumping Granules (Value)
      • 7.2.1. Global Anti-Bumping Granules by: Type (Value)
        • 7.2.1.1. Solid
        • 7.2.1.2. White
      • 7.2.2. Global Anti-Bumping Granules by: Application (Value)
        • 7.2.2.1. Laboratory chemicals
        • 7.2.2.2. Manufacture of substances,
        • 7.2.2.3. Scientific R&D
      • 7.2.3. Global Anti-Bumping Granules by: Type (Value)
        • 7.2.3.1. Solid
        • 7.2.3.2. White
      • 7.2.4. Global Anti-Bumping Granules by: Sale channel (Value)
        • 7.2.4.1. Online
        • 7.2.4.2. Offline
        • 7.2.4.3. Retailer
        • 7.2.4.4. Distributor
        • 7.2.4.5. Hypermarket/supermarket
        • 7.2.4.6. Others
      • 7.2.5. Global Anti-Bumping Granules Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Anti-Bumping Granules (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Anti-Bumping Granules: by Type(USD Million)
  • Table 2. Anti-Bumping Granules Solid , by Region USD Million (2015-2020)
  • Table 3. Anti-Bumping Granules White , by Region USD Million (2015-2020)
  • Table 4. Anti-Bumping Granules: by Application(USD Million)
  • Table 5. Anti-Bumping Granules Laboratory chemicals , by Region USD Million (2015-2020)
  • Table 6. Anti-Bumping Granules Manufacture of substances, , by Region USD Million (2015-2020)
  • Table 7. Anti-Bumping Granules Scientific R&D , by Region USD Million (2015-2020)
  • Table 8. Anti-Bumping Granules: by Type(USD Million)
  • Table 9. Anti-Bumping Granules Solid , by Region USD Million (2015-2020)
  • Table 10. Anti-Bumping Granules White , by Region USD Million (2015-2020)
  • Table 11. Anti-Bumping Granules: by Sale channel(USD Million)
  • Table 12. Anti-Bumping Granules Online , by Region USD Million (2015-2020)
  • Table 13. Anti-Bumping Granules Offline , by Region USD Million (2015-2020)
  • Table 14. Anti-Bumping Granules Retailer , by Region USD Million (2015-2020)
  • Table 15. Anti-Bumping Granules Distributor , by Region USD Million (2015-2020)
  • Table 16. Anti-Bumping Granules Hypermarket/supermarket , by Region USD Million (2015-2020)
  • Table 17. Anti-Bumping Granules Others , by Region USD Million (2015-2020)
  • Table 18. South America Anti-Bumping Granules, by Country USD Million (2015-2020)
  • Table 19. South America Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 20. South America Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 21. South America Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 22. Brazil Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 23. Brazil Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 24. Brazil Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 25. Argentina Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 26. Argentina Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 27. Argentina Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 28. Rest of South America Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 31. Asia Pacific Anti-Bumping Granules, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 34. Asia Pacific Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 35. China Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 36. China Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 37. China Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 38. Japan Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 39. Japan Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 40. Japan Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 41. India Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 42. India Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 43. India Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 44. South Korea Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 45. South Korea Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 46. South Korea Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 47. Taiwan Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 48. Taiwan Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 49. Taiwan Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 50. Australia Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 51. Australia Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 52. Australia Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 56. Europe Anti-Bumping Granules, by Country USD Million (2015-2020)
  • Table 57. Europe Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 58. Europe Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 59. Europe Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 60. Germany Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 61. Germany Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 62. Germany Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 63. France Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 64. France Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 65. France Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 66. Italy Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 67. Italy Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 68. Italy Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 69. United Kingdom Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 70. United Kingdom Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 71. United Kingdom Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 72. Netherlands Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 73. Netherlands Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 74. Netherlands Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 75. Rest of Europe Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 76. Rest of Europe Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 77. Rest of Europe Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 78. MEA Anti-Bumping Granules, by Country USD Million (2015-2020)
  • Table 79. MEA Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 80. MEA Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 81. MEA Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 82. Middle East Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 83. Middle East Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 84. Middle East Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 85. Africa Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 86. Africa Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 87. Africa Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 88. North America Anti-Bumping Granules, by Country USD Million (2015-2020)
  • Table 89. North America Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 90. North America Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 91. North America Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 92. United States Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 93. United States Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 94. United States Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 95. Canada Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 96. Canada Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 97. Canada Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 98. Mexico Anti-Bumping Granules, by Application USD Million (2015-2020)
  • Table 99. Mexico Anti-Bumping Granules, by Type USD Million (2015-2020)
  • Table 100. Mexico Anti-Bumping Granules, by Sale channel USD Million (2015-2020)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Anti-Bumping Granules: by Type(USD Million)
  • Table 118. Anti-Bumping Granules Solid , by Region USD Million (2021-2026)
  • Table 119. Anti-Bumping Granules White , by Region USD Million (2021-2026)
  • Table 120. Anti-Bumping Granules: by Application(USD Million)
  • Table 121. Anti-Bumping Granules Laboratory chemicals , by Region USD Million (2021-2026)
  • Table 122. Anti-Bumping Granules Manufacture of substances, , by Region USD Million (2021-2026)
  • Table 123. Anti-Bumping Granules Scientific R&D , by Region USD Million (2021-2026)
  • Table 124. Anti-Bumping Granules: by Type(USD Million)
  • Table 125. Anti-Bumping Granules Solid , by Region USD Million (2021-2026)
  • Table 126. Anti-Bumping Granules White , by Region USD Million (2021-2026)
  • Table 127. Anti-Bumping Granules: by Sale channel(USD Million)
  • Table 128. Anti-Bumping Granules Online , by Region USD Million (2021-2026)
  • Table 129. Anti-Bumping Granules Offline , by Region USD Million (2021-2026)
  • Table 130. Anti-Bumping Granules Retailer , by Region USD Million (2021-2026)
  • Table 131. Anti-Bumping Granules Distributor , by Region USD Million (2021-2026)
  • Table 132. Anti-Bumping Granules Hypermarket/supermarket , by Region USD Million (2021-2026)
  • Table 133. Anti-Bumping Granules Others , by Region USD Million (2021-2026)
  • Table 134. South America Anti-Bumping Granules, by Country USD Million (2021-2026)
  • Table 135. South America Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 136. South America Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 137. South America Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 138. Brazil Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 139. Brazil Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 140. Brazil Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 141. Argentina Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 142. Argentina Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 143. Argentina Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 144. Rest of South America Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 145. Rest of South America Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 146. Rest of South America Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 147. Asia Pacific Anti-Bumping Granules, by Country USD Million (2021-2026)
  • Table 148. Asia Pacific Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 149. Asia Pacific Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 150. Asia Pacific Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 151. China Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 152. China Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 153. China Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 154. Japan Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 155. Japan Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 156. Japan Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 157. India Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 158. India Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 159. India Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 160. South Korea Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 161. South Korea Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 162. South Korea Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 163. Taiwan Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 164. Taiwan Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 165. Taiwan Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 166. Australia Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 167. Australia Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 168. Australia Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 169. Rest of Asia-Pacific Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 170. Rest of Asia-Pacific Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 171. Rest of Asia-Pacific Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 172. Europe Anti-Bumping Granules, by Country USD Million (2021-2026)
  • Table 173. Europe Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 174. Europe Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 175. Europe Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 176. Germany Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 177. Germany Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 178. Germany Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 179. France Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 180. France Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 181. France Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 182. Italy Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 183. Italy Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 184. Italy Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 185. United Kingdom Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 186. United Kingdom Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 187. United Kingdom Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 188. Netherlands Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 189. Netherlands Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 190. Netherlands Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 191. Rest of Europe Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 192. Rest of Europe Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 193. Rest of Europe Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 194. MEA Anti-Bumping Granules, by Country USD Million (2021-2026)
  • Table 195. MEA Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 196. MEA Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 197. MEA Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 198. Middle East Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 199. Middle East Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 200. Middle East Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 201. Africa Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 202. Africa Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 203. Africa Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 204. North America Anti-Bumping Granules, by Country USD Million (2021-2026)
  • Table 205. North America Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 206. North America Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 207. North America Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 208. United States Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 209. United States Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 210. United States Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 211. Canada Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 212. Canada Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 213. Canada Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 214. Mexico Anti-Bumping Granules, by Application USD Million (2021-2026)
  • Table 215. Mexico Anti-Bumping Granules, by Type USD Million (2021-2026)
  • Table 216. Mexico Anti-Bumping Granules, by Sale channel USD Million (2021-2026)
  • Table 217. Research Programs/Design for This Report
  • Table 218. Key Data Information from Secondary Sources
  • Table 219. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Anti-Bumping Granules: by Type USD Million (2015-2020)
  • Figure 5. Global Anti-Bumping Granules: by Application USD Million (2015-2020)
  • Figure 6. Global Anti-Bumping Granules: by Type USD Million (2015-2020)
  • Figure 7. Global Anti-Bumping Granules: by Sale channel USD Million (2015-2020)
  • Figure 8. South America Anti-Bumping Granules Share (%), by Country
  • Figure 9. Asia Pacific Anti-Bumping Granules Share (%), by Country
  • Figure 10. Europe Anti-Bumping Granules Share (%), by Country
  • Figure 11. MEA Anti-Bumping Granules Share (%), by Country
  • Figure 12. North America Anti-Bumping Granules Share (%), by Country
  • Figure 13. Global Anti-Bumping Granules share by Players 2020 (%)
  • Figure 14. Global Anti-Bumping Granules share by Players (Top 3) 2020(%)
  • Figure 15. Global Anti-Bumping Granules share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Troemner LLC (United States) Revenue, Net Income and Gross profit
  • Figure 18. Troemner LLC (United States) Revenue: by Geography 2020
  • Figure 19. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck (United States) Revenue: by Geography 2020
  • Figure 21. Breckland Scientific (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Breckland Scientific (United Kingdom) Revenue: by Geography 2020
  • Figure 23. VWR International, LLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. VWR International, LLC (United Kingdom) Revenue: by Geography 2020
  • Figure 25. BASF (Germany) Revenue, Net Income and Gross profit
  • Figure 26. BASF (Germany) Revenue: by Geography 2020
  • Figure 27. Arkema (France) Revenue, Net Income and Gross profit
  • Figure 28. Arkema (France) Revenue: by Geography 2020
  • Figure 29. Nippon Shokubai (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Nippon Shokubai (Japan) Revenue: by Geography 2020
  • Figure 31. Mitsubishi Chemical (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Mitsubishi Chemical (Japan) Revenue: by Geography 2020
  • Figure 33. LG Chemical (South Korea) Revenue, Net Income and Gross profit
  • Figure 34. LG Chemical (South Korea) Revenue: by Geography 2020
  • Figure 35. Evonik Industries (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Evonik Industries (Germany) Revenue: by Geography 2020
  • Figure 37. Dow Chemical Company (United States) Revenue, Net Income and Gross profit
  • Figure 38. Dow Chemical Company (United States) Revenue: by Geography 2020
  • Figure 39. Hexion(United States) Revenue, Net Income and Gross profit
  • Figure 40. Hexion(United States) Revenue: by Geography 2020
  • Figure 41. OJSC Sibur (Moscow) Revenue, Net Income and Gross profit
  • Figure 42. OJSC Sibur (Moscow) Revenue: by Geography 2020
  • Figure 43. Sasol (South Africa) Revenue, Net Income and Gross profit
  • Figure 44. Sasol (South Africa) Revenue: by Geography 2020
  • Figure 45. Momentive Specialty Chemicals (United States) Revenue, Net Income and Gross profit
  • Figure 46. Momentive Specialty Chemicals (United States) Revenue: by Geography 2020
  • Figure 47. Thomas Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 48. Thomas Scientific (United States) Revenue: by Geography 2020
  • Figure 49. Global Anti-Bumping Granules: by Type USD Million (2021-2026)
  • Figure 50. Global Anti-Bumping Granules: by Application USD Million (2021-2026)
  • Figure 51. Global Anti-Bumping Granules: by Type USD Million (2021-2026)
  • Figure 52. Global Anti-Bumping Granules: by Sale channel USD Million (2021-2026)
  • Figure 53. South America Anti-Bumping Granules Share (%), by Country
  • Figure 54. Asia Pacific Anti-Bumping Granules Share (%), by Country
  • Figure 55. Europe Anti-Bumping Granules Share (%), by Country
  • Figure 56. MEA Anti-Bumping Granules Share (%), by Country
  • Figure 57. North America Anti-Bumping Granules Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Troemner LLC (United States)
  • Merck (United States)
  • Breckland Scientific (United Kingdom)
  • VWR International, LLC (United Kingdom)
  • BASF (Germany)
  • Arkema (France)
  • Nippon Shokubai (Japan)
  • Mitsubishi Chemical (Japan)
  • LG Chemical (South Korea)
  • Evonik Industries (Germany)
  • Dow Chemical Company (United States)
  • Hexion(United States)
  • OJSC Sibur (Moscow)
  • Sasol (South Africa)
  • Momentive Specialty Chemicals (United States)
  • Thomas Scientific (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation